Background: To address low human papillomavirus (HPV) vaccination coverage, the American Academy of Family Physicians (AAFP) and the American Academy of Pediatrics (AAP) have launched national campaigns encouraging physicians to deliver strong HPV vaccine recommendations. We surveyed family physicians and pediatricians to examine the impact of these efforts on physicians' recommendation practices.
A bout 79 million Americans currently are infected with human papillomavirus (HPV), and about 14 million are newly infected each year. 1 To prevent HPV infection, the Advisory Committee on Immunization Practices (ACIP) has recommended routine administration of the 3-dose HPV vaccine series to 11-to 12-year-olds since 2006 for girls and 2011 for boys. 2 Despite these recommendations, only 42% of girls and 28% of boys, ages 13-17 years, had completed the HPV vaccine series as of 2015. 3 This low level of coverage is far below the Healthy People 2020 goal of 80% as well as what has been achieved in other countries, including the United Kingdom, Australia, Mexico, and Rwanda. 4 The Centers for Disease Control and Prevention (CDC) estimates that our failure to meet the Healthy People 2020 goal for HPV vaccination in the United States will lead to over 50,000 future cervical cancer cases for today's population of girls ages 12 years and younger. 5 For every additional year of low coverage, another 4400 girls will develop cervical cancer over the course of their lifetimes. 5 Given the substantial health benefits of HPV vaccination, increasing vaccine uptake among girls and boys is a national priority.
Barriers to the delivery of HPV vaccine are complex and include parental hesitancy, lack of awareness that the vaccine should be given to boys, and challenges related to the completion of the 3-dose series. 6 Nevertheless, successful delivery of HPV vaccine still depends to a large extent on healthcare providers' recommendation practices. 7 Most adolescents who receive a provider's recommendation for HPV vaccination are subsequently vaccinated. [8] [9] [10] However, parental reports suggest that only about half of age-eligible adolescents receive recommendations, 8, 9 and only about one third of physicians recommend HPV vaccination for most of their 11-to 12-year-old patients. 11 Provider characteristics associated with recommending HPV vaccination include physician specialty and knowledge and attitudes about HPV vaccinations. 11 Consistent with other cancer prevention services, providers typically report that they are motivated to follow HPV vaccination guidelines of professional organizations, such as the American Academy of Family Physicians (AAFP) and the American Academy of Pediatrics (AAP). [12] [13] [14] These organizations play a key role in developing and disseminating HPV vaccination guidelines and in providing opportunities for continuing medical education and immunization quality improvement. For example, AAFP and AAP have distributed "dear colleague" letters to physicians that urge them to "give a strong recommendation for HPV vaccine to increase uptake." 15 Professional organizations appear central to immunization quality improvement efforts, yet little is known about how their communications influence physicians' HPV vaccine recommendations.
To address this gap, we sought to assess the reach, content, and influence of professional organizations' communications about HPV vaccination. We hypothesized that among physicians who reported being reached by professional organizations, they would indicate greater awareness of HPV vaccination practice guidelines and be more likely to deliver guideline-consistent recommendations. By exploring the relationship between professional organizations' communication and physicians' recommendation practices, we sought to understand mechanisms for disseminating information about HPV vaccine to providers and promoting uptake among adolescents.
METHODS

Participants and Procedures
The physician communication about HPV Vaccination Study was an online survey of US family physicians and pediatricians conducted from April to June 2014. As described previously, respondents were members of an existing national panel of physicians maintained by a survey research company. 16, 17 Constructed using American Medical Association lists, the panel included similar numbers of family physicians (51%) and pediatricians (49%) from all regions of the United States (22% northeast; 23% midwest; 37% south; 18% west). 18 Eligible physicians for our survey provided preventive care to patients ages 11 and 12 years because national guidelines specify this age range for routine HPV vaccination.
Of 2368 physicians invited by email to participate, 1022 (43%) responded by accessing the survey website, of which three quarters (76%) were eligible and completed the survey. 16 We were unable to collect data on ineligible respondents, though a third (33%) of physicians in the panel completed the survey. 16 Participants provided informed consent and received up to US $45 for completing the survey. 16 The University of North Carolina Institutional Review Board approved all procedures for this study.
Measures
Our survey assessed whether physicians reported having received information about HPV vaccines from 6 different sources with 1 item: "From which of these organizations have you directly received letters, emails, or other information about HPV vaccine in the last year?" Sources were: "Drug companies"; "Insurance companies"; "American Academy of Family Physicians (AAFP)"; "American Academy of Pediatrics (AAP)"; "the Centers for Disease Control and Prevention"; and the "President's Cancer Panel." For physicians who indicated receiving information from AAFP or AAP, a follow-up item assessed the content of that communication in terms of 5 messages: "HPV vaccination rates are too low"; "It is important to identify parents' concerns before recommending HPV vaccine"; "My recommendation should be based on adolescents' risk of getting HPV"; and "I should give a strong recommendation for HPV vaccine to all 11-to 12-year old [males/females]." A second follow-up item assessed the influence of the communication with the following response options: "Made me discuss it more often"; "Made me recommend it more often"; "Made me recommend it more strongly"; or "Had no effect." Finally, two items assessed physicians' knowledge of their professional organization's position of supporting routine HPV vaccination for 11-and 12-year-old boys and girls. Response options were: "No position"; "Physicians can give HPV vaccine at their discretion"; "Physicians should routinely give them HPV vaccine"; or "Not sure." These two items specified AAFP for family physicians and AAP for pediatricians.
To explore physicians' recommendation practices, we assessed quality of their HPV vaccine communication using a measure that we have previously reported. 16 This measure consisted of 5 quality indicators: timeliness for males (routinely recommending HPV vaccine by ages 11-12 years as per national guidelines), timeliness for girls, strength of endorsement (saying HPV vaccine is highly important for this age group), consistency (avoiding risk-based approaches to recommending HPV vaccine), and urgency (recommending same-day vaccination). We calculated recommendation quality by awarding each quality indicator one point for a total score ranging from 0 to 5. For our analysis, we categorized physicians as using "high-quality" recommendation practices if they received a score of 4 or higher or "lowquality" recommendation practices if they received a score of 3 or lower.
We collected respondents' demographic and professional characteristics including: medical specialty, sex, years in practice since residency, number of adolescent patients seen in a typical week, and percentage of vaccine doses delivered through the Vaccines for Children (VFC) program, which provides free vaccines to vulnerable populations. 19 For clinical characteristics, we assessed clinic type (private practice vs other), total number of physicians in the clinic, and state in which the clinic was located. We categorized clinic locations by US region using US Census classifications. 20 The full survey instrument is available online (www.unc. edu/~ntbrewer/hpv.htm).
Statistical Analysis
We used bivariate logistic regression to assess correlates of knowing professional organizations' positions for routine HPV vaccination of 11-to 12-year-old boys and girls. We then entered statistically significant correlates into multivariate models. To assess associations between organizational communication and physicians' HPV vaccine recommendation quality, we used χ 
RESULTS
Sample Characteristics
Our sample (n = 776) consisted of 366 family physicians (47%) and 410 pediatricians (53%), of whom about two thirds (68%) were boys (Table 1) . 18 Most were in private practice (85%), worked in clinics with 2 or more physicians (85%), and saw over 10 adolescent patients per week (83%). Physicians' practices were located in the northeast (24%), midwest (21%), south (35%), and west (20%) of the United States.
Organizational Reach
Overall, 47% of family physicians reported receiving information from AAFP, and 62% of pediatricians reported receiving information from AAP (Fig. 1) . Other information sources were drug companies (52%), the CDC (31%), insurance companies (9%), and the President's Cancer Panel (2%). Among physicians who received any information, 82% heard from at least 1 nonprofit source (ie, AAP, CDC, AAFP, or the President's Cancer Panel). Twenty-four percent of physicians reported not receiving information from any of the sources listed.
Content and Perceived Influence of Organizational Communication
Among physicians who reported receiving information from professional organizations, most reported hearing from AAFP or AAP that they should give strong recommendations for HPV vaccine to all 11-to 12-year-old boys and girls (Table 2) . At least half (53%) of physicians who reported receiving information from AAFP (53%) or AAP (72%) heard that HPV vaccination rates are too low. Smaller proportions heard that it is important to identify parents' concerns about HPV vaccination and few physicians reported hearing that recommendations should be based on adolescents' risks of getting HPV. A number of physicians reached by AAFP or AAP indicated that the information made them discuss HPV vaccination more often (36% and 26%, respectively), recommend it more often (35% and 25%), or recommend it more strongly (27% and 29%). Several physicians reached by AAFP (31%) or AAP (47%) reported that the information had no effect.
Knowledge of Professional Organizations' Position on HPV Vaccination
When asked to identify their professional organizations' positions on HPV vaccination for boys, 56% of family physicians and 85% of pediatricians knew that AAFP or AAP recommended routine vaccination at ages 11 and 12 years. Few physicians incorrectly reported that the recommendation for boys was to give HPV vaccine at the physician's discretion (14% and 5%) or that professional organizations had no position (<1% and <1%), or reported being unsure of the position (29% and 9%). For girls, 66% of family physicians and 90% of pediatricians knew that AAFP or AAP recommended routine vaccination at ages 11 and 12 years. Few reported incorrectly that the recommendation for girls was to give HPV vaccines at the physician's discretion (8% and 3%) or that professional organizations had no position (1% and <1%), or reported being unsure of the position (25% and 7%).
Bivariate analyses suggested several correlates of knowing the position for boys and girls (Table 1 ), yet these variables did not retain significance in multivariable models. In multivariable analyses, knowing AAFP or AAP's position on HPV vaccination for boys was less common for family physicians versus pediatricians (odds ratio [OR], 0.30; 95% confidence interval [CI], 0.18-0.48), and was more common for physicians who provided 10% to 49% Items assessing knowledge of professional organizations' positions specified AAFP for family physicians and AAP for pediatricians. * P < 0.05. ** P < 0.01.
Physician Recommendations for HPV Vaccination
Sexually 
HPV Vaccine Recommendation Quality
Physicians who reported receiving information from AAFP (among family physicians) or AAP (among pediatricians) were not more likely to have high HPV vaccine recommendation quality scores than those who did not receive information from these sources (Fig. 2, panel A) . Physicians who reported that they had versus had not heard from AAFP or AAP to give strong recommendations were more likely to have high recommendation quality scores for boys (57% vs 24%; χ 2 = 39.87; P < 0.001) and for girls (54% vs 27%; χ 2 = 21.81; P < 0.001; Fig. 2, panel B) . Similarly, physicians who reported that they did versus did not know their professional organization's positions on HPV vaccination were more likely to have high recommendation quality scores for boys (54% vs 26%; χ 2 = 48.14; P < 0.001) and for girls (52% vs. 25%; χ 2 = 37.26; P < 0.001; Fig. 2 , panel C).
DISCUSSION
In this survey of family physicians and pediatricians, we found that professional organizations' communication about HPV vaccination was positively associated with physicians' knowledge and recommendation practices. Most physicians reached by AAFP or AAP reported receiving the message that they should deliver strong recommendations for HPV vaccination to 11-and 12-year-old patients. Similarly, physicians reached by professional organizations had higher odds of knowing their professional organizations' position for routine HPV vaccination of patients in this age range. Although receiving information was not associated with using higher-quality communication practices Content and influence assessed among physicians who reported receiving information from AAP (n = 311) or AAFP (n = 178).
to recommend HPV vaccination, receiving the message to deliver strong recommendations and knowing professional organizations' position were associated with recommendation quality. Our findings support previous studies about the importance of HPVendorsement by professional organizations on physicians' recommendation practices. 21, 22 Importantly, our findings suggest that professional organizations' communications about HPV vaccination may play a role in influencing physicians' knowledge and recommendation practices related to HPV vaccination.
Our findings also show that the reach of these organizations may be somewhat limited. Fewer than half of family physicians reported receiving information from AAFP, and less than two thirds of pediatricians reported receiving information from AAP. Family physicians indicated that they were less likely than pediatricians to know their professional organization's positions on HPV vaccination. However, among family physicians who reported receiving information, most (69%) said they improved their recommendation practices by discussing HPV vaccination more often, recommending it more often, or recommending it more strongly, as a result. Increasing the intensity of professional organizations' quality improvement efforts, particularly for family physicians, is likely needed to extend their reach, clarify their positions on HPV vaccination, and maximize their influence on physicians' recommendation practices.
Professional organizations have recently launched initiatives to accomplish this goal. Most notably, AAP partnered with the CDC to develop practice tools and provide outreach and training to physician's offices. 23 Products of this collaboration include the HPV vaccination "Champion Toolkit," which emphasizes the need for providers to recommend vaccination for all boys and girls at ages 11-12 years. 24 Recently developed materials also include "Provider Resources for Vaccine Conversations with Parents," created by the CDC, AAFP, and AAP to help providers communicate more effectively with parents about vaccinating their children. 25 Because many physicians in our study reported improving their HPV vaccine recommendation practices as a result of information they received from AAFP or AAP, these recent efforts may help to improve HPV vaccination coverage. However, given the importance of communicating the need for strong recommendations, further research that experimentally tests these messages on physician behaviors is needed to more fully understand their impact.
Our findings also suggest that care is needed to craft messages that effectively communicate professional organizations' positions for routine HPV vaccination. Although physicians who reported being reached by AAFP or AAP were more likely to know their professional organizations' position, the correlation was not perfect; for example, 28% of physicians reached by AAFP did not know the position for boys. Although physicians may be receiving the information, the purpose of these messages is not being effectively conveyed. Ineffective messaging may explain why receiving information was not associated with higher-quality HPV vaccine recommendation practices. Future research could support professional organizations' quality improvement efforts by developing and testing messages that effectively communicate the goal of routine and timely HPV vaccine delivery.
Our study is among the first to evaluate HPV vaccinerelated communications from professional organizations, which prior research suggests are influential for informing primary care physicians' vaccine recommendation practices. 21, 26 Despite barriers to HPV vaccination, a systematic review found that physician recommendations were a primary predictor of successful vaccination uptake. 27 Limitations with our study should be considered. Given our cross-sectional design, we cannot draw causal inferences regarding the associations between professional organizations' communications and physicians' knowledge and recommendation practices. Our self-reported data are similarly subject to social-desirability bias, which may have led physicians to overestimate the quality of their HPV vaccination recommendation practices. A modest response rate (33%) is another limitation, especially given that respondents previously agreed to be on the survey panel, although physician surveys are often subject to challenges with response rates. 28, 29 Furthermore, because our sample came from a standing national panel, our findings may reflect the views of physicians who are more likely to participate in research activities, and may not generalize to other physicians. We also acknowledge that we did not have information on length or frequency of messaging, precluding an assessment of dose effect. Nevertheless, we collected information on type of content physicians received from professional organizations, which allowed us to explore associations between content and physician practice. Messages communicated by professional organizations are likely similar in terms of content, which may have led to some degree of misclassification in physicians' reports of message source. Finally, future research is needed to assess the influence of other important information sources about HPV vaccine, including CDC and drug companies.
CONCLUSIONS
Organizational change theory suggests that disseminating new tools and practices is often heavily dependent on opinion leaders, 30 and in the case of HPV vaccination, these leaders appear to include professional organizations like AAFP and AAP. Our study suggests that professional organizations' messages about HPV vaccination were associated with physicians' knowledge and recommendation practices, and that physicians perceived these communications as influential. However, several physicians reported not being reached by a professional organization and a substantial minority did not know their organization's position for routine HPV vaccination of boys and girls. Although there are many steps between intent and delivery of HPV vaccination, our study suggests that forthcoming initiatives by professional organizations that address these informational needs may make a difference in HPV vaccination acceptance through physician recommendations. It is noteworthy that one of our main findings suggests that physicians who received or did not receive information from AAFP or AAP reported no differences in HPV vaccine recommendation quality. Therefore, to ensure that all physicians are receiving accurate messaging about HPV vaccination recommendations, future research should seek to evaluate these efforts to better understand the role that professional organizations play in disseminating practice guidelines.
